Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation: a systematic review and meta-analysis

Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer

(2010) Stephen G. Swisher et al.   ANNALS OF THORACIC SURGERY

Serum CYFRA21-1 as a prognostic marker for patients with undifferentiated nasopharyngeal carcinoma

(2010) Wan-Qi Zhu et al.   BIOMARKERS

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography

(2010) Srikrishna V. Patnana et al.   CANCER

Predictive Value of Initial PET-SUVmax in Patients with Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma

(2010) Nabil P. Rizk et al.   Journal of Thoracic Oncology

The Standardized Uptake Value of 18-Fluorodeoxyglucose Positron Emission Tomography after Chemoradiation and Clinical Outcome in Patients with Localized Gastroesophageal Carcinoma

(2010) Santosh B. Murthy et al.   ONCOLOGY

The influence of 18flourodeoxyglucose positron emission tomography on the management of gastroesophageal junction carcinoma

(2009) Jason W. Smith et al.   AMERICAN JOURNAL OF SURGERY

Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation

(2009) Heta Javeri et al.   CANCER

The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma

(2009) Heta Javeri et al.   CANCER

Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis

(2009) LingLing Pan et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy

(2009) Michelle A.T. Hildebrandt et al.   JOURNAL OF CLINICAL ONCOLOGY

Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project

(2009) Thierry Berghmans et al.   Journal of Thoracic Oncology

Enabling personalized cancer medicine through analysis of gene-expression patterns

(2008) Laura J. van 't Veer et al.   NATURE

Translating insights from the cancer genome into clinical practice

(2008) Lynda Chin et al.   NATURE

The cancer biomarker problem

(2008) Charles L. Sawyers   NATURE

Adenocarcinomas of the esophagus: Response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET–CT

(2008) Johannes B. Roedl et al.   RADIOTHERAPY AND ONCOLOGY

Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus

(2007) B. M. Smithers et al.   DISEASES OF THE ESOPHAGUS